Personal hygiene brand Pee Safe has raised $32 million (around ₹290 crore) in a Series C funding round led by global healthcare-focused private equity firm OrbiMed Asia Partners, along with participation from existing investors.
The company plans to use the fresh capital to expand its offline retail network, strengthen brand marketing, and scale its presence across quick commerce and online marketplaces.
Pee Safe Funding Details
The Series C funding round included a mix of primary and secondary share investments, according to the company’s official statement.
With the new investment, Pee Safe aims to accelerate its next phase of growth in India’s fast-growing personal hygiene and women’s wellness market.
The company did not disclose the exact breakdown of primary versus secondary capital in the round.
Expansion Plans for Retail and Digital Channels
Pee Safe plans to use the new funding to strengthen both offline and online distribution channels.
Key growth plans include:
- Expanding its offline retail footprint
- Increasing brand-led marketing initiatives
- Growing presence on quick commerce platforms
- Scaling sales through online marketplaces and e-commerce platforms
The company already has a strong retail presence across India and aims to further increase its market penetration.
Pee Safe’s Product Portfolio
Founded by Vikas Bagaria, Pee Safe focuses on addressing gaps in women’s hygiene and personal care products.
The company offers products across multiple categories, including:
- Toilet hygiene products
- Feminine hygiene products
- Intimate care solutions
- Personal grooming and wellness products
Its product range is currently available in 50,000 retail outlets across more than 100 cities in India.
In addition to offline retail, Pee Safe products are also sold through major e-commerce and quick commerce platforms.
Financial Growth and Revenue Performance
Pee Safe has been witnessing steady growth in recent years.
The company reported annualised net revenue exceeding ₹150 crore.
According to financial data:
- FY25 revenue: ₹82 crore
- FY24 revenue: ₹56 crore
- Revenue growth: 46% year-on-year
At the same time, the company has significantly reduced its losses. Pee Safe reported a loss of ₹4 crore in FY25, showing improved financial discipline.
Previous Funding Rounds
Before this Series C round, Pee Safe had raised approximately $16.5 million in total funding, according to startup data platform Traxcn.
Key previous investments include:
- $3 million funding in 2023 from investors led by Natco Pharma and Rainmatter Health
- Earlier investments led by Alkemi Growth Capital
The latest funding round marks a major step in the company’s growth journey.
Growing Opportunity in Women’s Health Market
India’s women’s health and hygiene market is rapidly expanding as awareness increases and social taboos around personal hygiene gradually reduce.
Pee Safe’s founder Vikas Bagaria said the company was built to address an underserved category and challenge long-standing societal barriers related to women’s health products.
With increasing demand for personal care and hygiene products, the company sees strong opportunities for expansion in both urban and emerging markets.
Conclusion
With $32 million in Series C funding, Pee Safe is entering a new phase of expansion in India’s personal hygiene and wellness industry.
By strengthening its retail distribution, brand marketing, and quick commerce presence, the company aims to reach more consumers and scale its business across the country.
As the demand for women’s hygiene and wellness products continues to grow, Pee Safe is positioning itself as a leading player in India’s consumer healthcare sector.
